← Back to headlines
Analysis on Bristol Myers Squibb Stock and Dividend Yield
An analysis explores whether investors should consider buying Bristol Myers Squibb stock, focusing on its 4.4%-yielding dividend.
23 Mar, 20:50 — 23 Mar, 20:50
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippines No Longer Southeast Asia's Worst for Fuel Price Hikes, Economic Pain Persists
just now
Bohol Governor Orders Austerity for May Fiestas Amid Economic Pressures
just now
Philippines Police Boost Market Patrols Amid Price Freeze
just now